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Summary: A sensitive and specific Immunoturbidimetric method is described for the determination of low
concentrations of urinary albumin using a Hitachi 704 or 705 analyser. The sensitivity was l mg/1 and the
precision attained was good (CV 15%, 7% and 6% for low, medium and higher albumin concentrations).
The assay was used to determine urinary albumin excretion rates in healthy controls (< 15 μg/min) and in
type I diabetics. Since microalbuminuria (30—200 μg/min) seems to be a gpod predictor for the development
of diabetic nephropathy and other late diabetic complications, this assay is suitable for the necessary screening
and follow-up of diabetic nephropathy. In contrast to RIA methods, no radioactive tracers are needed.
Introduction
Nephropathy is one of the severe late complications
in diabetes mellitus, which res lts in a high morbidity
up to haemodialysis and a high mortality. By the
time renal function tests become abnormal and albu-
minuria is detectable by Standard clinical tests, dia-
betic nephropathy is irreversible (1). However, glyc-
aemic and blood pressure control (l, 2) might retard
or arrest the progression of diabetic nephropathy in
the state of microalbuminuria (3, 4). The degree of
microalbuminuri is also predictive of the progression
to clinical proteinuria in type I (5—7) and in type II
(8) diabetics. Furtherm re the percentage of patients
with low abnormal albumin excretion rates (30—
200 μέ/πιίη) that have retinopathy is higher than in
normal albuminuric patients (< 20 — 30 μ£/πώι) and
the risk for the development of proliferative retinopa-
thy is high (6,9).
Radioimmunoassays have been developed to detect
microalbuminuria (10,11) with the obvious disadvan-
tage of radioactive tracers. Low concentrations of
albumin can also be ineasured by radial-immunodif-
fusion (7, 12). Immunoturbidimetric methods for the
measurement of albumin have been published (4, 13,
14). We present the adaptation of an immunoturbidi-
metric method for the determination of low concen-
trations of albumin in uri e to a Hitachi analyser
type 704 or 705, that enables routine measurements
of urine samples in a short time (180 samples per
hour) at low cost.
Materials and Methods
Reagents
Polyethyleneglycol 6000 (PEG) was obtained from Merck-
Schuohardt, Hohenbrunn, FRG. The assay buffer contained
per litre: 50 mmol phosphate, 100 mmol NaCl, 40 g PEG 6000
and l g NaN3. The pH was adjusted to 7.4. In the following
this buffer is referred to s PBS-PEG. Purified, lyophilized
human albumin was purchased from Behringwerke AG, Mar-
burg, FRG. Solutions eontaining 2.5, 5,10, 20, 40 and 80 mg/1
human albumin were prepared in the buffer described above.
An anti-human-albumin-antibody (AI 19) was obtained from
Dakopatts, Hamburg, FRG. The antibody was prediluted in
buffer and centrifuged at 3000 £ for 15 min before use.
All other reagents were of analytical grade.
Turbidimetric measurement of albumin
Initially a modification of published methods (4, 13, 14) using
an Eppendorf Photometer with glass microcuvettes was used.
The method was then adapted to an Hitachi analyser type 704,
frequently used in clinical chemistry. Twenty microlitres of the
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albumin-containing solution or of the urine sample were mixed
with 330 PBS-PEG and preincubated for 5 minutes at 30 °C.
Then 50 of diluted antibody solution were added, followed
by anolher 5 minutes incubation at 30 °C. The absorbance was
measured bichromatically at wavelengths 340 and 700 nm.
Radioimmunoassay of albumin
Fourty two urine probes were measured with a commercially
available radioimmunoassay (Pharmacia, Uppsala, Schweden).
Urine collection
Thirty five healthy women and 30 healthy men (mean age 33
years, ränge 17 — 54 years), äs well äs 15 diabetic men and 14
diabetic women (mean age 33 years, ränge 14—76 yeafs) pro-
vided overnight urine, using the following procedure. They
passed urine immediately before going to bed, discarded this
sample and recorded the time. The urine passed during the
night and immediately after they got up in the morning was
collected without preservative, the volume measured and the
time recorded.
Furthermore, 3 healthy men and 6 healthy women (mean age
28 years, ränge 21—46 years) äs well äs 14 diabetic men and 4
diabetic women (mean age 33 years, ränge 19 — 64 years) col-
lected urine-.qver 24 hours during normal daily activities without
extreme muscular exercise.
Urine samples were frozen at — 20 °C. Before the assay the
samples were centrifuged for 2 min at 9000 g in an Eppendorf
centrifuge 3200.
Results
Figure l (left) depicts the absorbance changes with
time at different albumin concentrations (5 — 80
mg/1), measured with an Hitachi 704. After addition
of the anti-alburnin-antibody the absorbance in-
creases rapidly and levels off after about 120 seconds.
There is a linear relationship between the absorbance
and the albumin concentration at the plateau level
(flg. l right). The curves were not different if albumin
was added to PBS-PEG or to albumin-free urine.
Albumin-containing urines sltyw the same kinetics of
absorbance äs the albumin-containing buffer solü-
tions (not showri). Therefore albumin in urine can
easily be determined by comparison with albumin
Standards dissolved in buffer.
The mean values of Standard albumin concentrations
obtained in ten different assays on the Hitachi 704
are depicted in figure 2.
The dilution curve of a urine containing 76 mg/1
albumin feil exactly on the albumin Standard curve,
irrespective of the dilution medium (PBS-PEG or
albumin-free urine; fig. 3). Up to 80 mg/1 albumin
the absorbance changes were independent of the final
dilution of the antialbümin antibody (l: 40, l: 80 or
l: 160). However, at higher albumin concentrations
a loss of linearity was observed and false low values
were measured, especially when high antibody dilu-
tions were used (fig. 4). Therefore the first urine
sample of each pätient was estimated undiluted and
at a 1:2 dilution. During follow-up of the diabetic
patients with albuminuria under 100 mg/1, urine was
estimated undiluted; for cpncentrations aböve 100
mg/1 the urine was diluted. A rather high antibody
concentration (l: 40) was used to assure that the
antibody was present in excess.
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Fig. 1. Left: Absorbance changes with time at different albumin concentrations. The absorbance of the albumin-containing
Solutions were measured with an Hitachi analyser type 704. After a preineubation "of 300 seconds anti-albumin antibody
was added and the absorbance recorded at 20 seconds intervals.
Right: The absorbance values measured at 300 seconds after addition of the antibody were pjotted against the albumin
concentrations.
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Fig. 2. Albumin concentrations in Standard albumin Solutions
are plotted against the differences of the absorbance at
340 nm and 700 nm, measured 300 seconds after addi-
tion of the antibody solution (l :40). The curve rep-
resents the mean ± SEM of ten different assays.
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Fig. 3. Dilution curve of an albumin-containing urine. The
dilution medium was PBS-PEG (closed Symbols) or
albumin-free ürine (open Symbols). The solid line rep-
resents the curve obtained with Standard albumin solu-
tions.
The intra- and interässay Väriations of teil determiiia-
tions of three urine samples with different intrinsic
albumin concentrations are depicted in table 1.
The validity of the turbidimetric assay was tested
against a radioimmunoassay.
The values analysed by the immunoturbidimetric
method were oa average somewhat higher than those
measured by RIA.
There was a highly significant correlation between
the values measured by the radioimmunoassay and
the turbidimetric method (r = 0.983; p < 0.001;
fig. 5).
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Fig. 4. The difTerence of the absorbance at 340 nm and 700
nm of albumin Standard Solutions measured 300
seconds after the addition of different antibody dilu-
tions is plotted against the albumin concentrations. The
final dilutions of the antialbumin-antibody were l: 160
(a), 1:80 ( ), and 1:40 (A).
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Fig. 5. Comparison of albumin concentration values measured
by radioimmunoassay and turbidimetric assay in 42
urine samples:
r = 0.983; p < 0.001.
Tab. 1. Intra- and inter-assay Variation of ten immuno-turbidi-
metric measurements of albumin in urine on the Hitachi
704.
Variation
Intra-assay
Inter-assay
Albumin concentration
mean
(mg/1)
3.0
44.2
74.0
3.2
43.0
71.4
SD
(mg/1)
0.0
0.6
1.8
0.4
3.0
4.2
CV
(%)
0.0
1.4
2.5
13.0
7.0
5.9
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Albumin measurements in ur ine of healthy
and diabetic persons
The mean albumin excretion rates, measured in over-
night urines of 65 healthy persons was 4.7 μ§/ππη
± 5.1 (mean ± S. D.), the two S. D. r nge being Ο-
Ι 4.9 μg/min. The albumin excretion in urines col-
lected by nine control persons over 24 hours were
well within this r nge (3.2 ± 1.8 μg/min, r nge 0 — 5
μg/min). There was no significant difference in the
overnight albumin excretion rates in males and fe-
males (males 4.5 ± 3.5 μg/min n = 30, females: 4.9
± 6.3 μg/min, n = 35).
Out of 29 diabetic patients, 19 had overnight albumin
excretion rates within the normal r nge, 10 ranged
from 91 to 3850 μg/min, and five of them were
negative by albustix.
Eighteen type I diabetic patients provided urine over
24 hours. Fourteen diabetics had albumin excretion
rates below 20 μg/min and the three others were 544,
636 and 14,98 μg/min. The last three were also positive
by albustix.
Fourteen of these patients collected 24-hour urine
seven times at two-week intervals. The mean values
of these seven samples of each patient are shown
in table 2. This table demonstrates the well known
variance in albumin excretion rates, also within the
normal r nge. Three patients had low but pathologi-
cal values (20 — 200 μg/min) at least on one occasion,
which underlines the necessity of repeated examina-
tions at short intervals in these cases before the diag-
nosis of microalbuminuria can be confirmed. It fur-
thermore enables intensified control, which might
Tab. 2. Mean of seven albumin excretion rates in 14 diabetic
patients.
Patient
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Mean
0.4
2
2
2
2
2
4
5
6
7
8
11
829
1338
S.D.
fag/min)
0.8
1
2
2
2
6
2
4
3
5
11
9
173
353
Range
(μ§/ηιίη)
0-2
0^3
0-6
0-6
0-6
0-15
1-8
0-10
1-10
3-17
2-30
3-22
636-1187
771-1969
prevent an increase in albumin excretion rates s the
result of irreversible diabetic nephropathy.
Discussiop
The adaptation of an imm noturbidimetric method
for measuring albumin to the Hitachi nalyser, an
apparatus used in many laboratories for routine clini-
cal chemistry, provides a rapid and inexpensive
method for the measurement of albumin in urine
below levels detectable by Standard laboratory
methods. In addition, no radioactive isotopes are
needed.
Using an Hitachi 704 we established an upper limit
of normal for the albumin excretion rate of 15 μg/
min (mean ± 2 S. D.; n = 65) which is comparable
to the values in the literature using RIA methods or
radial immunodiffusion (6, 7, 15).
The sensitivity of the assay was l mg/l, the interassay
coefficients of Variation at 3 mg/1, 40 mg/1 and 70
mg/1 albumin were 13%, 7% and 6% respectively.
Therefore the method is sensitive and precise enough
to measure the low albumin coneentrations present
in normal urine and in diabetic microalbuminuria.
The fast assay time, low cost and good precision
makes this the method of choice for routine albumin
determination.
Since the values found in control and diabetic persons
are comparable with th se published (2, 4—9, 15 —
18), this imm noturbidimetric assay is suitable for
the screening and follow Up of early diabetic nephro-
pathy. This is important since the degree of microal-
buminuria seems to be a good predictor for clinical
nephropathy and retinopathy (5—9). Since a small
increase in microalbuminuria might be reversible by
strict blood glucose and blood pressure control (3, 4)
a routine check-up for microalbuminuria every three
months seems to be advisable (16). When values
between 20 and 200 μ£/ηώι albumin excretion rate
are found, two controls at short time intervals are
necessary to confirm the diagnosis of microalbuminu-
ria.
Timed overnight urine collection was chosen s a
convenient and practicable method for most patients.
It avoids the effects of posture and different degrees
of physical exercise on albuminuria, especially seen
in diabetics (15, 17, 18), although not.observed in the
small number of diabetics presented in this communi-
cation.
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